A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Clinical trial NCT04207801 · COMPLETED

Trial details

NCT number: NCT04207801
Sponsor: Aurigene Discovery Technologies Limited
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Plaque-type Psoriasis

Start date: 2020-01-21
Primary completion: 2021-03-20
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.